Abstract
Autosomal recessive osteopetrosis (ARO) is a rare genetic disorder caused by impaired osteoclast activity. In this study, we describe a 4-year-old boy with increased bone density due to osteopetrosis, autosomal recessive 8. Using genome sequencing, we identified a large deletion in the 5′-untranslated region (UTR) of SNX10 (sorting nexin 10), where the regulatory region of this gene is located. This large deletion resulted in the absence of the SNX10 transcript and led to abnormal osteoclast activity. SNX10 is one of the nine genes known to cause ARO, shown to interact with V-ATPase (vacuolar type H( + )-ATPase), as it plays an important role in bone resorption. Our study highlights the importance of regulatory regions in the 5′-UTR of SNX10 for its expression while also demonstrating the importance of genome sequencing for detecting large deletion of the regulatory region of SNX10.
Introduction
Osteopetrosis is a form of skeletal dysplasia characterized by increased bone density due to decreased osteoclast activity [1]. The severity of this disease ranges from asymptomatic to very mild to fatal in infancy. Autosomal recessive osteopetrosis (ARO) is a rare, heterogeneous group of osteopetrosis disorders with an estimated incidence of 1 in 250,000 newborns [2]. The characteristic features of this disease are increased bone density, visual impairment, hepatomegaly, splenomegaly, and bone marrow failure. SNX10 is one of nine genes (OSTM1, CLCN7, CA2, TNFSF11, TNFRSF11A, PLEKHM1, TCIRG1, and FERMT3) responsible for autosomal recessive osteopetrosis [3]. SNX10 has been shown to interact with V-ATPase (vacuolar type H( + )-ATPase), which helps in pumping protons into the osteoclast bone lacunae [4]. In addition, SNX10 is involved in intracellular vesicular trafficking and plays an important role in maintaining bone homeostasis [5]. To date, 16 variants in SNX10 have been reported in 45 individuals with osteopetrosis, autosomal recessive 8, in the Human Gene Mutation Database (http://www.hgmd.cf.ac.uk/ac/index.php, last accessed April 20, 2022). Here, we describe a 4-year-old boy with a large homozygous deletion in the 5′-untranslated region (5′-UTR) of SNX10 causing osteopetrosis autosomal recessive 8 with milder phenotypes.
Methods
Written informed consent was obtained from participants before sample collection. Blood was drawn from the proband, and his parents in EDTA vacutainers. Genomic DNA was isolated by the phenol-chloroform method.
Exome and genome sequencing and data analysis
Exome sequencing was performed using the Agilent SureSelect CREv2 Capture Kit and sequenced on the NovaSeq 6000 (Illumina Inc. USA).
Further, genome sequencing was performed with targeted coverage of 40× using NovaSeq 6000 (Illumina Inc. USA). Raw reads were aligned to the reference genome GRCh38. Delly was used to detect copy number variations and structural variations, and those variants involving known genes were further analyzed. A detailed protocol of data processing, variant calling, derivation of allele frequencies and allele states, and variant annotation was described in our previous study [6]. The UCSC browser was used to examine regulatory regions and to search for promoter/enhancer binding sites for the identified variants. The large deletion identified during genome sequencing was validated by GAP PCR with primers flanking the deleted region followed by Sanger sequencing.
Reverse transcription PCR
Reverse transcription PCR (RT-PCR) was performed with RNA extracted from white blood cells using RiboPure™ RNA Purification Kit (Invitrogen), and cDNA was prepared using SuperScriptTM IV VILOTM Master Mix (Invitrogen). Two different primer sets were used to perform RT-PCR (listed in Table 1). RT-PCR products were checked by 1% agarose gel electrophoresis.
Clinical report
A 4-year-old male child of a second-degree consanguineous couple (Fig. 1A) was examined. He was born at term by normal vaginal delivery with a birth weight of 3.5 kg (−0.10 SD). At the age of 3 years, he was hospitalized for fever. At 4 years of age, he was 98 cm (−1 SD) tall, weighed 14.0 kg (−1.4 SD), and had a head circumference of 51 cm (+0.38 SD). Blood investigations revealed anaemia, thrombocytopenia and elevated lactate dehydrogenase (1047 U/L; reference value: 225–460 U/L). Physical examination revealed a large skull, frontal bossing and pectus carinatum (Fig. 1B). These observations were similar to those of affected individuals described in the previous reports [7, 8]. His hearing was normal, and the other developmental stages were also age-appropriate. We did not observe any visual impairment in him at this age. However, at the age of 5 years and 2 months, he developed a vision problem and bilateral optic atrophy was diagnosed. Hepatosplenomegaly and mesenteric lymphadenopathy were also noted. We found no neurologic abnormalities in the proband. Blood tests revealed a low haemoglobin level and decreased white blood cells and platelet counts. Further details of the biochemical investigations are given in Table 2.
Complete skeletal examination revealed increased bone density at the outer cranial cortex, epiphyses, and metaphyses. A moderate increase in bone density and irregular transparency of the diaphysis were noted at the tibia. The proband was found to have an increased width of the ribs, and radiographs of the spine showed “sandwich vertebrae” and a bone-in-bone appearance (Fig. 1C–G).
Exome sequencing revealed no significant disease-causing variants. Genome sequencing analysis using the in-house variant prioritization strategy revealed a large homozygous deletion of 72,012 bp, which was confirmed by manual analysis of the BAM file using Integrative Genomics Viewer. This deletion includes upstream region of SNX10, the noncoding exon 1, and a portion of intron 1 (Fig. 2A). GAP PCR and Sanger sequencing confirmed the deletion of 72,012 bp along with the insertion of two nucleotides (NC_000007.14:g.26263639_26335651delinsCA) in the proband (Fig. 2B). Both parents were carriers of the indel. This variant is not included in any of the control population databases.
Further mRNA analysis using RT-PCR with the primer set for exon 1 and7 of SNX10 showed the expected band size (559 bp) in the control, the absence of PCR product in the proband, while the parents showed normal DNA band size (559 bp) due to a normal allele in them. Another primer set including only exon 6 and 7 of SNX10 showed a very weak band (105 bp) in the proband, indicating a lower amount of SNX10 transcript compared to the control and healthy parents. RT-PCR for GAPDH was used for control normalization (Fig. 3).
Discussion
We present a patient with autosomal recessive osteopetrosis 8. The clinical features of the proband are typical of the ARO phenotype such as increased bone density, large skull, bone-in-bone, thrombocytopenia, hepatosplenomegaly, loss of vision and “sandwich vertebrae”. We identified a deletion-insertion variant, NC_000007.14:g.26263639_26335651delinsCA in the homozygous state on chromosome 7 by genome sequencing. Exome sequencing failed to identify the large deletion because it encompasses a large noncoding region including the intergenic region upstream of SNX10, there showing that exome sequencing is not an ideal method for identifying large deletions in noncoding regions. Genome sequencing identified the exact breakpoints of the 72,012 bp long region encompassing the regulatory region of SNX10. The parents are healthy carriers of the same variant. Initially, we thought that due to the deletion of the 5′-UTR and exon 1 region of SNX10, there might be no SNX10 transcript, but a study by Ye et al., 2015 [9] showed severe osteopetrosis but no rickets in the osteoclast-specific SNX10 knockout. However, our patient showed a moderate phenotype without rickets. Further mRNA analysis revealed the presence of a lower amount of SNX10 transcript. Therefore, we hypothesize that the decreased amount of SNX10 transcript results in abnormal endosome sorting and vesicular transport to osteoclast bone lacunae.
Homozygous loss-of-function variants in SNX10 leading to “osteoclast-rich” ARO were first described in Palestinian families [10]. It is estimated that SNX10 is involved in 5% of all cases of ARO [7]. SNX10 belongs to the family of sorting nexins that regulate endosome sorting and vesicular trafficking [11, 12]. SNX10 is also responsible for vesicular targeting of V-ATPase at the ruffled boundary. Loss-of-function variants in SNX10 result in secondary impairment of V-ATPase and failure to acidify the resorption lacuna [13]. A homozygous ~70 kb deletion chr7:g.(26249558_26251671)-(26321193_26322492) in SNX10 identified by 1 M array comparative genomic hybridization was previously reported with osteopetrosis [14]. Our ~72 kb deletion of the noncoding region partially overlaps with the reported ∼70 kb deletion. In our study, mRNA analysis was also performed by RT-PCR, which confirmed the deletion of the SNX10 regulatory region, which had not been described previously. Non-coding region deletions involving regulatory elements have a significant impact on human development and health. Deleterious remote regulatory element mutations are well studied in the Van Buchem disease, a sclerosing bone dysplasia, and shown its effects on the transcriptional regulation of nearby genes.
Our study expands the molecular spectrum of SNX10 mutations and identifies a novel mechanism of deletion of the upstream and untranslated region that is likely still underdiagnosed due to technical limitations. This study highlights the importance of genome sequencing for uniform coverage of noncoding regions, which helped us to identify the precise breakpoints of the identified deletion. In addition, our study fills the gap in studying the functional impact of a large deletion in SNX10.
Web resources
-
1.
PRIMER 3 v.4.1.0, http://primer3.ut.ee/
-
2.
Ensembl, https://asia.ensembl.org/index.html
- 3.
-
4.
OMIM, https://www.omim.org/
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.
- 12.
-
13.
CROSSMAP, http://crossmap.sourceforge.net/
-
14.
PanelApp, https://panelapp.genomicsengland.co.uk/
-
15.
UCSC, https://genome.ucsc.edu/
- 16.
References
Teti A, Econs MJ. Osteopetroses, emphasizing potential approaches to treatment. Bone 2017;102:50–9.
Palagano E, Menale C, Sobacchi C, Villa A. Genetics of Osteopetrosis. Curr Osteoporos Rep. 2018;16:13–25.
Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A. 2019;179:2393–419.
Zhu CH, Morse LR, Battaglino RA. SNX10 is required for osteoclast formation and resorption activity. J Cell Biochem. 2012;113:1608–15.
Elson A, Stein M, Rabie G, Barnea-Zohar M, Winograd-Katz S, Reuven N, et al. Sorting Nexin 10 as a Key Regulator of Membrane Trafficking in Bone-Resorbing Osteoclasts: Lessons Learned From Osteopetrosis. Front Cell Dev Biol. 2021;9:671210.
Ghosh DK, Pande S, Kumar J, Yesodharan D, Nampoothiri S, Radhakrishnan P, et al. The E262K mutation in Lamin A links nuclear proteostasis imbalance to laminopathy-associated premature aging. Aging Cell. 2022;21:e13688.
Pangrazio A, Fasth A, Sbardellati A, Orchard PJ, Kasow KA, Raza J, et al. SNX10 mutations define a subgroup of human autosomal recessive osteopetrosis with variable clinical severity. J Bone Min Res. 2013;28:1041–9.
Mégarbané A, Pangrazio A, Villa A, Chouery E, Maarawi J, Sabbagh S, et al. Homozygous stop mutation in the SNX10 gene in a consanguineous Iraqi boy with osteopetrosis and corpus callosum hypoplasia. Eur J Med Genet. 2013;56:32–5.
Ye L, Morse LR, Zhang L, Sasaki H, Mills JC, Odgren PR, et al. Osteopetrorickets due to Snx10 deficiency in mice results from both failed osteoclast activity and loss of gastric acid-dependent calcium absorption. PLoS Genet. 2015;11:e1005057.
Aker M, Rouvinski A, Hashavia S, Ta-Shma A, Shaag A, Zenvirt S, et al. An SNX10 mutation causes malignant osteopetrosis of infancy. J Med Genet. 2012;49:221–6.
Cullen PJ. Endosomal sorting and signalling: an emerging role for sorting nexins. Nat Rev Mol Cell Biol. 2008;9:574–82.
Barnea-Zohar M, Winograd-Katz SE, Shalev M, Arman E, Reuven N, Roth L, et al. An SNX10-dependent mechanism downregulates fusion between mature osteoclasts. J Cell Sci. 2021;134:jcs254979.
Xu J, Qiu H, Zhao J, Pavlos NJ. The molecular structure and function of sorting nexin 10 in skeletal disorders, cancers, and other pathological conditions. J Cell Physiol. 2021;236:4207–15.
Baer S, Schaefer É, Michot C, Fischbach M, Morelle G, Bendavid M, et al. Intermediate autosomal recessive osteopetrosis with a large noncoding deletion in SNX10: A case report. Pediatr Blood Cancer. 2019;66:e27751.
Acknowledgements
The authors thank the patients and their family members for the participation in the study. This work is supported by the DBT/Wellcome Trust India Alliance Fellowship (India Alliance) under the project titled “Center for Rare Disease Diagnosis, Research and Training” (Grant ID: GR-0011; Reference number: IA/ CRC/20/1/600002) awarded to Girisha KM. This study was also supported by Department of Biotechnology, Government of India funded project titled ‘Development of genomic technologies for predictive genetic health and forensic profiling’ (Grant No. BTl/AAQ/01/CDFD-Flagship/2019) and Indian Council of Medical Research funded project titled “Indian Undiagnosed Diseases Program (I-UDP)” (33/9/2019-TF/Rare/BMS) to AD.
Funding
Open access funding provided by Manipal Academy of Higher Education, Manipal.
Author information
Authors and Affiliations
Contributions
PU: Methodology, investigation, formal analysis, writing the original draft. DKG: Methodology, formal analysis, validation. NK: Methodology, investigation, data curation. SB: Clinical evaluation, resource acquisition. HS: Clinical evaluation, resource acquisition. AD: Resource acquisition, formal analysis, validation, funding acquisition. KMG: Resource acquisition, clinical evaluation, formal analysis, validation, funding acquisition. GSL: Resource acquisition, formal analysis, validation, project administration, writing - review & editing, overall supervision. All authors have reviewed and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests. All the authors have read and approved the final paper.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Udupa, P., Ghosh, D.K., Kausthubham, N. et al. Genome sequencing identifies a large non-coding region deletion of SNX10 causing autosomal recessive osteopetrosis. J Hum Genet 68, 287–290 (2023). https://doi.org/10.1038/s10038-022-01104-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-022-01104-2